CJ, K., ST, L., YD, Q., X, Y., RF, L., CH, L., . . . WW, L. (2025). Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages. British journal of clinical pharmacology, 91(7), 1927. https://doi.org/10.1002/bcp.70016
Chicago Style (17th ed.) CitationCJ, Ke, Liu ST, Qian YD, You X, Lin RF, Lin CH, Huang PF, and Lin WW. "Physiologically Based Pharmacokinetic Model for Oxcarbazepine Active Metabolite to Predict Pharmacokinetics in Paediatric Patients with Renal Impairment and Adjust Dosages." British Journal of Clinical Pharmacology 91, no. 7 (2025): 1927. https://doi.org/10.1002/bcp.70016.
MLA (9th ed.) CitationCJ, Ke, et al. "Physiologically Based Pharmacokinetic Model for Oxcarbazepine Active Metabolite to Predict Pharmacokinetics in Paediatric Patients with Renal Impairment and Adjust Dosages." British Journal of Clinical Pharmacology, vol. 91, no. 7, 2025, p. 1927, https://doi.org/10.1002/bcp.70016.